These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38053928)
21. Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions. Su S; Di Poto C; Kroemer AH; Cui W; Roy R; Liu X; Ressom HW Exp Cell Res; 2019 Nov; 384(1):111621. PubMed ID: 31513782 [TBL] [Abstract][Full Text] [Related]
23. [Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency]. Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):539-547. PubMed ID: 33210478 [TBL] [Abstract][Full Text] [Related]
24. High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH. Shchelochkov OA; Li FY; Geraghty MT; Gallagher RC; Van Hove JL; Lichter-Konecki U; Fernhoff PM; Copeland S; Reimschisel T; Cederbaum S; Lee B; Chinault AC; Wong LJ Mol Genet Metab; 2009 Mar; 96(3):97-105. PubMed ID: 19138872 [TBL] [Abstract][Full Text] [Related]
26. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency. Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency. Ibrahim MS; Gold JI; Woodall A; Yilmaz BS; Gissen P; Stepien KM Children (Basel); 2023 Aug; 10(8):. PubMed ID: 37628367 [TBL] [Abstract][Full Text] [Related]
28. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency. Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167 [TBL] [Abstract][Full Text] [Related]
29. Neonatal Presentation of Ornithine Transcarbamylase Deficiency Associated With a Hypomorphic OTC Variant (p.Leu301Phe) Previously Reported in Later-Onset Disease. Anderson S; Ciarlariello M; Botti C; Velinov M Cureus; 2024 Aug; 16(8):e65956. PubMed ID: 39221296 [TBL] [Abstract][Full Text] [Related]
30. Hyperammonemia crisis following parturition in a female patient with ornithine transcarbamylase deficiency. Kido J; Kawasaki T; Mitsubuchi H; Kamohara H; Ohba T; Matsumoto S; Endo F; Nakamura K World J Hepatol; 2017 Feb; 9(6):343-348. PubMed ID: 28293384 [TBL] [Abstract][Full Text] [Related]
31. A simple screening method for heterozygous female patients with ornithine transcarbamylase deficiency. Iijima H; Kubota M Mol Genet Metab; 2022 Nov; 137(3):301-307. PubMed ID: 36252454 [TBL] [Abstract][Full Text] [Related]
32. In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency. Ozdemir Y; Cag M; Gul S; Yüksel Z; Ergoren MC Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):153-156. PubMed ID: 34670952 [TBL] [Abstract][Full Text] [Related]
33. Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice. Yamazaki K; Kubara K; Ishii S; Kondo K; Suzuki Y; Miyazaki T; Mitsuhashi K; Ito M; Tsukahara K Mol Ther Nucleic Acids; 2023 Sep; 33():210-226. PubMed ID: 37520683 [TBL] [Abstract][Full Text] [Related]
34. Lymphocyte mRNA analysis of the ornithine transcarbamylase gene in Italian OTCD male patients and manifesting carriers: identification of novel mutations. Giorgi M; Morrone A; Donati MA; Ciani F; Bardelli T; Biasucci G; Zammarchi E Hum Mutat; 2000 Apr; 15(4):380-1. PubMed ID: 10737985 [TBL] [Abstract][Full Text] [Related]
35. Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene. Jang YJ; LaBella AL; Feeney TP; Braverman N; Tuchman M; Morizono H; Ah Mew N; Caldovic L Hum Mutat; 2018 Apr; 39(4):527-536. PubMed ID: 29282796 [TBL] [Abstract][Full Text] [Related]
36. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations. Gao J; Gao F; Hong F; Yu H; Jiang P Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973 [TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency. Lu D; Han F; Qiu W; Zhang H; Ye J; Liang L; Wang Y; Ji W; Zhan X; Gu X; Han L Orphanet J Rare Dis; 2020 Dec; 15(1):340. PubMed ID: 33272297 [TBL] [Abstract][Full Text] [Related]
39. Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. Cavicchi C; Donati M; Parini R; Rigoldi M; Bernardi M; Orfei F; Gentiloni Silveri N; Colasante A; Funghini S; Catarzi S; Pasquini E; la Marca G; Mooney S; Guerrini R; Morrone A Orphanet J Rare Dis; 2014 Jul; 9():105. PubMed ID: 25026867 [TBL] [Abstract][Full Text] [Related]